Furthermore, Liu et al. indicate that SETD2 mutant/IDH wild-type (SETD2-mut/IDH-WT) GBM cells can activate a specific type of high-grade glioma-associated microglia (HGG-AM) by TGF-β1. The gene discussed is IDH1; the disease is glioma.